GlassScriptPhysician profile
James W Young
NPI 1669462925
$998.40
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $291 · 2021: $91.08 · 2023: $312 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.60 | 2023-2024 | Botox |
| Astellas Pharma US INC | $187.24 | 2019-2020 | |
| Boston Scientific Corporation | $127.09 | 2020 | |
| Pfizer INC. | $55.72 | 2020 | |
| Myovant Sciences INC. | $47.36 | 2021 | |
| Myriad Genetic Laboratories, INC. | $29.04 | 2021 | |
| Laborie Medical Technologies Corp. | $28.97 | 2020 | |
| Rochester Medical Corporation | $24.76 | 2020 | |
| Coloplast Corp | $15.18 | 2020 | |
| Acerus Pharmaceuticals Corporation | $14.68 | 2021 | |
| Dentsply Ih INC. | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.